Regional blood flow and cardiac responses to hydralazine.
作者信息
Spokas E G, Wang H H
出版信息
J Pharmacol Exp Ther. 1980 Feb;212(2):294-303.
PMID:7351643
Abstract
摘要
相似文献
1
Regional blood flow and cardiac responses to hydralazine.肼屈嗪对局部血流及心脏的反应。
J Pharmacol Exp Ther. 1980 Feb;212(2):294-303.
2
Cardiovascular actions of iproveratril.维拉帕米的心血管作用。
J Pharmacol Exp Ther. 1967 Dec;158(3):504-9.
3
Cardiovascular effects of YM099, a novel K+ channel opener, in anesthetized and conscious dogs.新型钾通道开放剂YM099对麻醉和清醒犬的心血管作用
Eur J Pharmacol. 1994 Nov 3;264(3):285-93. doi: 10.1016/0014-2999(94)00475-7.
4
Effects of hydralazine on regional blood flow in conscious dogs.肼屈嗪对清醒犬局部血流的影响。
J Pharmacol Exp Ther. 1986 Aug;238(2):665-9.
5
Cardiac output and regional blood flows during intravenous infusion of an amino acid mixture in dogs. IV.犬静脉输注氨基酸混合液时的心输出量和局部血流量。IV.
Acta Chir Scand. 1974;140(6):441-4.
6
Responses to exogenous adenosine 3',5'-monophosphate of cardiac output and blood flow in the renal, superior mesenteric and carotid arteries in anesthetized dogs.麻醉犬的心输出量以及肾动脉、肠系膜上动脉和颈动脉血流量对外源性3',5'-环磷酸腺苷的反应。
Tohoku J Exp Med. 1974 Feb;112(2):119-28. doi: 10.1620/tjem.112.119.
7
[Comparative animal experimental studies of the effectivity of various blood vessel and myocardium ACTIVE SUBSTANCES IN AN ACUTE TRIAL].[不同血管及心肌活性物质在急性试验中有效性的比较动物实验研究]
Z Gesamte Inn Med. 1969 Feb 15;24(4):102-8.
8
[Effect of prostaglandin F2alpha on the systemic and regional hemodynamics of dogs].[前列腺素F2α对犬全身及局部血流动力学的影响]
Farmakol Toksikol. 1977 Jan-Feb;40(1):44-50.
9
Cardiovascular pharmacological studies on JTV-506, a new potassium channel opener. 1st communication: effects on myocardium and vasculature.新型钾通道开放剂JTV-506的心血管药理学研究。首次通讯：对心肌和血管系统的作用
Arzneimittelforschung. 2000 Mar;50(3):236-43. doi: 10.1055/s-0031-1300192.
引用本文的文献
1
Clinical pharmacokinetics of hydralazine.肼屈嗪的临床药代动力学。
Clin Pharmacokinet. 1982 May-Jun;7(3):185-205. doi: 10.2165/00003088-198207030-00001.
2
Differential blockade of alpha-adrenoceptors by indoramin.吲哚拉明对α-肾上腺素能受体的选择性阻断作用
Br J Clin Pharmacol. 1984 Jun;17(6):719-28. doi: 10.1111/j.1365-2125.1984.tb02409.x.
3
Enhancement of muscle blood cell flux and pO2 by cromakalim (BRL 34915) and other compounds enhancing membrane K+ conductance, but not by Ca2+ antagonists or hydralazine, in an animal model of occlusive arterial disease.在闭塞性动脉疾病动物模型中，克罗卡林（BRL 34915）及其他增强膜钾离子电导的化合物可增强肌肉血细胞通量和氧分压，但钙拮抗剂或肼苯哒嗪则无此作用。
Naunyn Schmiedebergs Arch Pharmacol. 1988 Mar;337(3):341-6. doi: 10.1007/BF00168848.
4
Cardiovascular effects of the novel arteriovenous dilator agent, flosequinan in conscious dogs and cats.新型动静脉扩张剂氟司喹南对清醒犬猫的心血管作用
Br J Pharmacol. 1988 Jun;94(2):371-80. doi: 10.1111/j.1476-5381.1988.tb11539.x.
5
The measurement of norepinephrine clearance and spillover rate into plasma in conscious spontaneously hypertensive rats.清醒自发性高血压大鼠去甲肾上腺素清除率及向血浆溢出率的测定。
Naunyn Schmiedebergs Arch Pharmacol. 1988 Oct;338(4):350-60. doi: 10.1007/BF00172109.
6
Clinical pharmacokinetics and therapeutic use of hydralazine in congestive heart failure.肼屈嗪在充血性心力衰竭中的临床药代动力学及治疗应用
Clin Pharmacokinet. 1989 Feb;16(2):86-9. doi: 10.2165/00003088-198916020-00003.
Zotero 插件